Abbott: Diabetes Mellitus trials
The registry lists 48 Diabetes Mellitus studies with Abbott as lead sponsor. 0 are open to participants now and 10 have results posted.
Phase 1 1Phase 2 6Phase 3 6Phase 4 3No phase 33(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- FreeStyle Libre in Pregnancy StudyCompletedNCT02665455Not applicableResults posted
- Abbott Sensor Based Glucose Monitoring System Paediatric StudyCompletedNCT02388815Not applicableResults posted
- Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring SystemsCompletedNCT02283411Not applicableResults posted
- An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Diabetes (IMPACT)CompletedNCT02232698Not applicableResults posted
- An Evaluation of a Novel Glucose Sensing Technology in Type 2 DiabetesCompletedNCT02082184Not applicableResults posted
- Sensor and Software Use for Improved Glucose Control in MDI Managed DiabetesCompletedNCT01713348Phase 4Results posted
- Impact of a built-in Insulin Calculator Feature on Diabetes Control - Pilot StudyCompletedNCT01519466Not applicableResults posted
- Ease of Use of New Blood Glucose Meter With In-built Insulin Calculator at Home StudyCompletedNCT01432275Not applicableResults posted
- Use of the FreeStyle Navigator Continuous Glucose Monitoring System to Enhance Education and Glycaemic ControlCompletedNCT01214824Not applicableResults posted
- Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patients With High Risk of Developing Diabetes MellitusCompletedNCT01079195Results posted
- Diabetes-specific Formulas on Nutritional Outcomes in Individuals With Diabetes Who Require Nutritional SupportCompletedNCT06632002Not applicable
- Benefits of Nutritional Ingredients for Type 2 DiabetesWithdrawnNCT06327711Not applicable
- Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated With Basal Insulin in FinlandTerminatedNCT06268821Not applicable
- Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of MalnutritionCompletedNCT05913193
- Diabetes-specific Formula (DSF) in Individuals With Type 2 DiabetesCompletedNCT05802927Not applicable
- Study of an Interstitial Fluid Glucose SensorCompletedNCT05251116Not applicable
- FSL2 Post Approval Study for Pediatric and Young Adults PatientsActive, not recruitingNCT04959552
- Effect of the FreeStyle Libre 2 Flash Glucose Monitoring System on Hyperglycemia in People With T2 DiabetesCompletedNCT04604093
- Diabetes-Specific Formula on Long Term Glycemic ControlCompletedNCT04345497Not applicable
- Diabetes-Specific Formula in Individuals With Type 2 DiabetesCompletedNCT04303754Not applicable
- A Tube Feeding Study in Malnourished Population With DiabetesCompletedNCT03766620
- FreeStyle Libre Flash Glucose Monitoring System in Pediatric PopulationsCompletedNCT03369899
- FreeStyle Libre Flash Glucose Monitoring System AccuracyCompletedNCT03159546
- FreeStyle Libre Flash Glucose Monitoring System Accuracy StudyCompletedNCT03141892
- Effect of Nutritional Products in Subjects With Type 2 DiabetesCompletedNCT02923960Not applicable
- FreeStyle Libre Glucose Monitoring System Paediatric StudyCompletedNCT02821117Not applicable
- FreeStyle Libre Pro Use in Primary & Secondary CareCompletedNCT02434315Not applicable
- Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring SystemCompletedNCT02073058
- A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2WithdrawnNCT02009410Phase 4
- Accuracy Characterization StudyCompletedNCT01932944
- Evaluation of a Nutritional Product for People With Type 2 DiabetesCompletedNCT01850810Not applicable
- Evaluation of a Nutritional Supplement for People With Type 2 Diabetes.WithdrawnNCT01850134Not applicable
- Comparison Study of Blood Glucose Monitoring Systems in People With DiabetesCompletedNCT01234727
- Four-Hour Evaluation of a Medical Food in Subjects With Type 2 DiabetesCompletedNCT01188200Phase 3
- A Safety PK/PD Study of SLV337 in Patients With Type 2 DiabetesCompletedNCT00924534Phase 2
- Interaction Study SLV337/SimvastatinCompletedNCT00924430Phase 1
- Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Glucose Monitoring SystemCompletedNCT00920881
- Comparison of Nutritional Products for People With Type 2 DiabetesCompletedNCT00797069Phase 3
- Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 DiabetesCompletedNCT00753181Phase 3
- A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 DiabetesCompletedNCT00703482Phase 2
- Comparison of Enteral Products for Tube Fed Patients With Type 2 DiabetesCompletedNCT00544206Phase 2
- An Intervention Program to Control DiabetesCompletedNCT00543621Phase 4
- Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Specific vs Standard Nutritional FormulasCompletedNCT00540488Phase 3
- Comparison of Nutritional Products for People With Type 2 DiabetesCompletedNCT00520065Phase 2
- Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With Type 2 DiabetesCompletedNCT00499148Phase 2/3
- Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and DyslipidemiaCompletedNCT00490178Phase 3
- Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II DiabetesCompletedNCT00160160Not applicable
- Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 DiabetesCompletedNCT00141492Phase 2